Solution Group going regional


Upon obtaining the approval, Solution Group deputy group managing director Datuk Mohd Nazlee Kamal (file pic) told StarBiz, the company would produce between 30 million and 40 million doses for this year. Some of the vaccines would also be exported to South-East Asian countries.

KUALA LUMPUR: Solution Group Bhd, which has inked a deal with China’s CanSino Biologics Inc for the distribution of the Covid-19 vaccines in Malaysia, has started to plan for bigger things ahead.

The engineering and biopharmaceuticals company is looking to export the vaccines to the South-East Asia region.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Metal markets rush to adjust to clampdown
Apple’s US$1bil outlay may be a fleeting win
Nestl� Malaysia expands green programme to Sabah with partners
Google offers to loosen search agreements
Tether sees US$10bil in net profits for 2024
Qualcomm wins key chips trial against Arm
Higher gold prices expected to boost Malaysia’s exports
Demand for property to remain steady in 2025
Painting a brighter future
China property flare-ups resurface as crisis enters its fifth year

Others Also Read